A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors

A Aghanejad, SF Bonab, M Sepehri… - International journal of …, 2022 - Elsevier
Monoclonal antibodies (mAbs) as biological macromolecules have been remarked the large
and growing pipline of the pharmaceutical market and also the most promising tool in …

A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors

A Aghanejad, SF Bonab, M Sepehri… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) as biological macromolecules have been remarked the large
and growing pipline of the pharmaceutical market and also the most promising tool in …

A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors.

A Aghanejad, SF Bonab, M Sepehri… - … Journal of Biological …, 2022 - europepmc.org
Monoclonal antibodies (mAbs) as biological macromolecules have been remarked the large
and growing pipline of the pharmaceutical market and also the most promising tool in …

A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors

A Aghanejad, SF Bonab, M Sepehri… - … Journal of Biological …, 2022 - eprints.ssu.ac.ir
Monoclonal antibodies (mAbs) as biological macromolecules have been remarked the large
and growing pipline of the pharmaceutical market and also the most promising tool in …

A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors

A Aghanejad, SF Bonab, M Sepehri… - … Journal of Biological …, 2022 - eprints.ssu.ac.ir
Monoclonal antibodies (mAbs) as biological macromolecules have been remarked the large
and growing pipline of the pharmaceutical market and also the most promising tool in …

[引用][C] A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors

A Aghanejad, SF Bonab, M Sepehri, FS Haghighi… - 2022